NO20065063L - Anvendelse - Google Patents

Anvendelse

Info

Publication number
NO20065063L
NO20065063L NO20065063A NO20065063A NO20065063L NO 20065063 L NO20065063 L NO 20065063L NO 20065063 A NO20065063 A NO 20065063A NO 20065063 A NO20065063 A NO 20065063A NO 20065063 L NO20065063 L NO 20065063L
Authority
NO
Norway
Prior art keywords
glucose concentration
impaired
syndrome
disease associated
ketosis
Prior art date
Application number
NO20065063A
Other languages
English (en)
Norwegian (no)
Inventor
Leopold Franz Goetze
Jr Marcus Eugene Kehrli
Anthony Paul Ricketts
Patrick Carl Taube
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20065063L publication Critical patent/NO20065063L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Birds (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
NO20065063A 2004-05-25 2006-11-02 Anvendelse NO20065063L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57413604P 2004-05-25 2004-05-25
PCT/IB2005/001501 WO2005115369A2 (fr) 2004-05-25 2005-05-13 Nouvelle utilisation

Publications (1)

Publication Number Publication Date
NO20065063L true NO20065063L (no) 2006-12-01

Family

ID=35207497

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065063A NO20065063L (no) 2004-05-25 2006-11-02 Anvendelse

Country Status (13)

Country Link
US (1) US20070232647A1 (fr)
EP (1) EP1765320A2 (fr)
JP (1) JP2008500328A (fr)
CN (1) CN101123956A (fr)
AU (1) AU2005247172A1 (fr)
BR (1) BRPI0511613A (fr)
CA (1) CA2568009A1 (fr)
IL (1) IL178984A0 (fr)
MX (1) MXPA06013674A (fr)
NO (1) NO20065063L (fr)
RU (1) RU2342130C2 (fr)
WO (1) WO2005115369A2 (fr)
ZA (1) ZA200609104B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070281935A1 (en) * 2004-05-25 2007-12-06 Pfizer Inc. Use
UA107938C2 (en) * 2009-08-12 2015-03-10 Syngenta Participations Ag Heterocycles with microbicidal properties
WO2012009542A2 (fr) * 2010-07-14 2012-01-19 Kansas State University Research Foundation Procédés de soulagement de la douleur chronique et d'amélioration de la performance du bétail subissant un écornage ou une castration
US20180279651A1 (en) * 2015-10-08 2018-10-04 Nisso Fine Co., Ltd. Feed composition
WO2018218020A1 (fr) * 2017-05-24 2018-11-29 Rupca Llc Synthèse de maillard à pression réduite d'un supplément énergétique glucidique pour le bétail ruminant
EP3590354A1 (fr) * 2018-07-02 2020-01-08 PerformaNat GmbH Additif alimentaire contenant un modulateur de trp
WO2020007819A1 (fr) * 2018-07-02 2020-01-09 Performanat Gmbh Additif alimentaire comprenant un modulateur de trp
BR112021007591A2 (pt) * 2018-10-23 2021-07-27 D.I.T Technologies Ltd composições para administração a animais ruminantes
US11389418B2 (en) 2018-12-20 2022-07-19 One Idea LLC Protection of polyunsaturated fatty acids from ruminal degradation
CN113040291A (zh) * 2021-04-07 2021-06-29 华东师范大学 PPARγ激活剂在提高水生动物抵抗环境应激能力中的应用
CN116162056A (zh) * 2021-11-24 2023-05-26 上海医药工业研究院 β-catenin/BCL9蛋白-蛋白相互作用的小分子抑制剂及其应用
WO2024145931A1 (fr) * 2023-01-06 2024-07-11 上海医药工业研究院有限公司 INHIBITEUR À PETITES MOLÉCULES POUR L'INTERACTION PROTÉINE-PROTÉINE β-CATÉNINE/BCL9 ET UTILISATION ASSOCIÉE

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2191007C2 (ru) * 1996-05-24 2002-10-20 Лиганд Фармасьютикалз Инкорпорейтед Способ лечения иhcд агонистами rxr
FI109324B (fi) * 1998-11-06 2002-07-15 Rehuraisio Oy Rehu ja menetelmä sen valmistamiseksi
US6875780B2 (en) * 2002-04-05 2005-04-05 Warner-Lambert Company Compounds that modulate PPAR activity and methods for their preparation
PT1567493E (pt) * 2002-11-26 2009-04-09 Pfizer Prod Inc Activadores de ppar
GB0314624D0 (en) * 2003-06-23 2003-07-30 Advanced Bionutrition Europ Lt Inflammatory disease treatment
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20070281935A1 (en) * 2004-05-25 2007-12-06 Pfizer Inc. Use

Also Published As

Publication number Publication date
JP2008500328A (ja) 2008-01-10
WO2005115369A3 (fr) 2006-11-16
US20070232647A1 (en) 2007-10-04
RU2342130C2 (ru) 2008-12-27
EP1765320A2 (fr) 2007-03-28
CA2568009A1 (fr) 2005-12-08
CN101123956A (zh) 2008-02-13
BRPI0511613A (pt) 2008-01-02
IL178984A0 (en) 2007-05-15
ZA200609104B (en) 2008-09-25
MXPA06013674A (es) 2007-02-13
WO2005115369A2 (fr) 2005-12-08
AU2005247172A1 (en) 2005-12-08
RU2006140689A (ru) 2008-06-27

Similar Documents

Publication Publication Date Title
NO20065063L (no) Anvendelse
Keeton et al. Coccidiosis in large and small ruminants
Schweer et al. The effect of porcine reproductive and respiratory syndrome virus and porcine epidemic diarrhea virus challenge on growing pigs I: growth performance and digestibility
AU2015347971B2 (en) Oral rehydration composition and methods thereof
Ávila et al. Impact of a tannin extract on digestibility, ruminal fermentation and duodenal flow of amino acids in steers fed maize silage and concentrate containing soybean meal or canola meal as protein source
Novriadi et al. Comparative effect of advanced soy products or corn protein concentrate with porcine meal on growth, body composition, and distal intestine histology of Florida pompano, Trachinotus carolinus
Rodrigues et al. Effects of oral meloxicam administration to beef cattle receiving lipopolysaccharide administration or vaccination against respiratory pathogens
Moriel et al. Decreasing the frequency and rate of wet brewers grains supplementation did not impact growth but reduced humoral immune response of preconditioning beef heifers
Wang et al. Effects of keratinase supplementation of corn-soybean meal based diets on apparent ileal amino acid digestibility in growing pigs and serum amino acids, cytokines, immunoglobulin levels and loin muscle area in nursery pigs
BRPI0511481A (pt) uso
Espinosa et al. Growth performance of weanling pigs fed diets containing spray-dried bovine plasma or hydrolyzed spray-dried bovine plasma
Crenshaw et al. Effects of a nursery feed regimen with spray-dried bovine plasma on performance and mortality of weaned pigs positive for porcine reproductive and respiratory syndrome virus
Jeong et al. Effect of soybean meal and soluble starch on biogenic amine production and microbial diversity using in vitro rumen fermentation
US10660926B2 (en) Thermo-modified nutshells and methods of treating diarrhea, adsorbing toxins, promoting growth and improving the overall health
Hall The evaluation of dietary betaine, pre and probiotics, transitional substrates, and β-mercaptoacetate on physiological, metabolic, hormonal and production responses in lactating Holstein cows subjected to thermal stress
Silva et al. Impacts of polyclonal antibody preparations from avian origin on nutrient digestibility and performance of backgrounding beef cattle
Baumgartner Diarrhoea in calves and young cattle.
Vanderhoof Early changes in the human Microbiome alter immune function and immunologically mediated disorders
Johns Managing acute colitis in the adult horse
Erasmus et al. Effect of Virginiamycin and Poulcox, or both, on performance of Holstein cows.
Marini et al. The effect of immunization with jackbean urease on antibody response and nitrogen recycling in mature sheep
Gaschen How I treat chronic canine enteropathies-old and new options.
Modir et al. Effects of L-carnitine on treatment outcomes of COVID-19 patients hospitalized in intensive care units: A double-blind randomized clinical trial
Solimana et al. Scientific Journal of Veterinary Advances
Castro et al. Importance of breast milk in the development of intestinal microbiota

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application